ATE506947T1 - Kondensierte thiophene verbindungen und deren verwendung zur behandlung von chronischen schmerzen - Google Patents
Kondensierte thiophene verbindungen und deren verwendung zur behandlung von chronischen schmerzenInfo
- Publication number
- ATE506947T1 ATE506947T1 AT02731200T AT02731200T ATE506947T1 AT E506947 T1 ATE506947 T1 AT E506947T1 AT 02731200 T AT02731200 T AT 02731200T AT 02731200 T AT02731200 T AT 02731200T AT E506947 T1 ATE506947 T1 AT E506947T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- chronic pain
- thiophene compounds
- condensed thiophene
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28041601P | 2001-03-30 | 2001-03-30 | |
PCT/US2002/009943 WO2002083083A2 (en) | 2001-03-30 | 2002-03-29 | Pharmaceutically active compounds and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE506947T1 true ATE506947T1 (de) | 2011-05-15 |
Family
ID=23072979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02731200T ATE506947T1 (de) | 2001-03-30 | 2002-03-29 | Kondensierte thiophene verbindungen und deren verwendung zur behandlung von chronischen schmerzen |
Country Status (15)
Country | Link |
---|---|
US (2) | US7101905B2 (de) |
EP (1) | EP1383463B1 (de) |
JP (1) | JP4303474B2 (de) |
KR (1) | KR100888093B1 (de) |
AT (1) | ATE506947T1 (de) |
AU (1) | AU2002303191B2 (de) |
BR (1) | BR0208593A (de) |
CA (1) | CA2443135C (de) |
DE (1) | DE60239864D1 (de) |
ES (1) | ES2365905T3 (de) |
IL (2) | IL158186A0 (de) |
MX (1) | MXPA03008936A (de) |
NZ (1) | NZ528635A (de) |
WO (1) | WO2002083083A2 (de) |
ZA (1) | ZA200308020B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60239864D1 (de) * | 2001-03-30 | 2011-06-09 | King Pharmaceuticals Inc | Kondensierte thiophene verbindungen und deren verwendung zur behandlung von chronischen schmerzen |
AR039280A1 (es) * | 2002-04-11 | 2005-02-16 | Smithkline Beecham Corp | Compuesto de aminotiofeno y su uso para preparar una composicion farmaceutica |
US20040087642A1 (en) * | 2002-10-24 | 2004-05-06 | Zeldis Jerome B. | Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain |
UA95641C2 (en) * | 2006-07-06 | 2011-08-25 | Эррей Биофарма Инк. | Hydroxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
US8063050B2 (en) | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
EP3010887A1 (de) * | 2013-06-21 | 2016-04-27 | LEK Pharmaceuticals d.d. | Herstellung von chiralen 1-methyl-2,3,4,5-1h-benzodiazepinen durch asymmetrische reduktion von alpha-substituierten styrolen |
TWI734699B (zh) * | 2015-09-09 | 2021-08-01 | 美商英塞特公司 | Pim激酶抑制劑之鹽 |
CN116410205A (zh) * | 2021-12-29 | 2023-07-11 | 上海皓元生物医药科技有限公司 | 一种3-取代-9-甲基-噻吩并三唑并噁嗪类化合物的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9401499D0 (sv) | 1994-05-02 | 1994-05-02 | Item Dev Ab | New method of treatment |
DE69721794T2 (de) | 1996-09-06 | 2004-03-18 | Takeda Chemical Industries, Ltd. | Kondensierte 4,5,6,7-tetrahydrobenzo c]thiophene als beschleuniger der wirkung des zelldifferenzierungsinduktionsfaktors |
US5939432A (en) | 1997-10-29 | 1999-08-17 | Medco Research, Inc. | Thiophenes useful for modulating the adenosine receptor |
GB9808665D0 (en) | 1998-04-23 | 1998-06-24 | Merck Sharp & Dohme | Therapeutic compounds |
DE60239864D1 (de) * | 2001-03-30 | 2011-06-09 | King Pharmaceuticals Inc | Kondensierte thiophene verbindungen und deren verwendung zur behandlung von chronischen schmerzen |
-
2002
- 2002-03-29 DE DE60239864T patent/DE60239864D1/de not_active Expired - Lifetime
- 2002-03-29 AT AT02731200T patent/ATE506947T1/de not_active IP Right Cessation
- 2002-03-29 US US10/112,613 patent/US7101905B2/en not_active Expired - Fee Related
- 2002-03-29 ES ES02731200T patent/ES2365905T3/es not_active Expired - Lifetime
- 2002-03-29 KR KR1020037012817A patent/KR100888093B1/ko not_active IP Right Cessation
- 2002-03-29 EP EP02731200A patent/EP1383463B1/de not_active Expired - Lifetime
- 2002-03-29 AU AU2002303191A patent/AU2002303191B2/en not_active Ceased
- 2002-03-29 WO PCT/US2002/009943 patent/WO2002083083A2/en active Search and Examination
- 2002-03-29 CA CA2443135A patent/CA2443135C/en not_active Expired - Fee Related
- 2002-03-29 MX MXPA03008936A patent/MXPA03008936A/es active IP Right Grant
- 2002-03-29 JP JP2002580888A patent/JP4303474B2/ja not_active Expired - Fee Related
- 2002-03-29 IL IL15818602A patent/IL158186A0/xx active IP Right Grant
- 2002-03-29 BR BRPI0208593-3A patent/BR0208593A/pt not_active Application Discontinuation
- 2002-03-29 NZ NZ528635A patent/NZ528635A/en not_active IP Right Cessation
-
2003
- 2003-09-30 IL IL158186A patent/IL158186A/en not_active IP Right Cessation
- 2003-10-15 ZA ZA200308020A patent/ZA200308020B/en unknown
-
2006
- 2006-04-11 US US11/402,240 patent/US7449490B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1383463B1 (de) | 2011-04-27 |
EP1383463A2 (de) | 2004-01-28 |
MXPA03008936A (es) | 2005-03-07 |
JP2005500994A (ja) | 2005-01-13 |
AU2002303191B2 (en) | 2007-01-18 |
WO2002083083A2 (en) | 2002-10-24 |
EP1383463A4 (de) | 2009-03-25 |
BR0208593A (pt) | 2006-02-21 |
US20030073733A1 (en) | 2003-04-17 |
US7449490B2 (en) | 2008-11-11 |
IL158186A0 (en) | 2004-03-28 |
CA2443135A1 (en) | 2002-10-24 |
DE60239864D1 (de) | 2011-06-09 |
JP4303474B2 (ja) | 2009-07-29 |
NZ528635A (en) | 2006-11-30 |
WO2002083083A3 (en) | 2003-11-06 |
KR100888093B1 (ko) | 2009-03-11 |
US7101905B2 (en) | 2006-09-05 |
ES2365905T3 (es) | 2011-10-13 |
US20060183921A1 (en) | 2006-08-17 |
ZA200308020B (en) | 2007-01-31 |
KR20040083335A (ko) | 2004-10-01 |
CA2443135C (en) | 2010-07-13 |
IL158186A (en) | 2011-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
DE60141230D1 (de) | Verwendung von Botulinum Toxin zur Behandlung von neuralgischen Schmerzen | |
DE60042984D1 (de) | Arzneitmittel zur Behandlung von Duchenne-Muskeldystrophie | |
DE60223694D1 (de) | Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums | |
ATE350375T1 (de) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen | |
ATE331512T1 (de) | Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie | |
ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
ATE451921T1 (de) | Phenylindole zur behandlung von hiv | |
DE60208221D1 (de) | Heterozyklische verbindungen zur behandlung von harnwegserkrankungen | |
ATE394103T1 (de) | Verwendung von rosuvastatin (zd-4522) zur behandlung von heterozygoter familiärer hypercholesterolämie | |
DE60208186D1 (de) | Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrinvermittelten erkrankungen | |
DE69925865D1 (de) | 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen | |
ATE428413T1 (de) | Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen | |
ATE346614T1 (de) | Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
DE602004003952D1 (de) | Substituierte tetrahydrobenzothienopyrimidinamine verbindungen geeignet zur behandlung von hyper-proliferative disorders | |
DE502004010131D1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
ATE369130T1 (de) | Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen | |
ATE522218T1 (de) | Dosierungseinheit enthaltend prostaglandin-analog zur behandlung von darmverstopfung | |
DE60238765D1 (de) | Carbamatverbindungen zur behandlung von schmerz | |
ATE312104T1 (de) | Verbindungen zur behandlung von beeinträchtigten fundischen entspannung | |
DE60214355D1 (de) | Exemestan zur behandlung von hormonabhängigen störungen | |
DE602004019576D1 (de) | Zur behandlung von schmerzen geeignete piperazine | |
DE60239864D1 (de) | Kondensierte thiophene verbindungen und deren verwendung zur behandlung von chronischen schmerzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |